Michael F. Mee, 51 years old, was named senior vice president and chief financial officer.
Mr. Mee succeeds Michael E. Autera, who had been chief financial officer for 17 years.
Mr. Autera currently heads the company's nutritional and health-care businesses.
The turmoil in the pharmaceutical industry will be familiar to Mr. Mee, who has a background in working with companies struggling with cyclical downturns or industry change.
In October, Mr. Mee resigned as chairman and chief financial officer of Wang Laboratories Inc., which he helped lead out of bankruptcy court.
He has also worked at Norton Co., Monsanto Co., and Chrysler Corp.
